Recovery Guide Intervention for Recurrent Psychiatric Hospitalization - Full Text View

Sponsors and Collaborators:	Yale University Connecticut State, Department of Mental Health and Addiction Services Eli Lilly and Company
Information provided by:	Yale University
ClinicalTrials.gov Identifier:	NCT00400166

Purpose

The purpose of this study is to determine whether Recovery Guide support services are effective in promoting recovery and social integration among psychiatrically disabled individuals who experience high rates of inpatient hospitalizations.

Condition	Intervention
Schizophrenia Schizoaffective Disorder Bipolar Disorder Psychotic Depression	Behavioral: Recovery Mentor

MedlinePlus related topics: Bipolar Disorder Depression Psychotic Disorders Schizophrenia

U.S. FDA Resources

Study Type:	Interventional
Study Design:	Supportive Care, Randomized, Open Label, Uncontrolled, Parallel Assignment, Efficacy Study
Official Title:	Recovery Guide Intervention for Recurrent Psychiatric Hospitalization

Further study details as provided by Yale University:

Primary Outcome Measures:

Number of hospitalizations [ Time Frame: 3 and 9 months ] [ Designated as safety issue: No ]
Number of treatment contacts [ Time Frame: 3 and 9 months ] [ Designated as safety issue: No ]

Secondary Outcome Measures:

Sense of community [ Time Frame: Baseline, 3 and 9 months ] [ Designated as safety issue: No ]
Motivation for change [ Time Frame: Baseline, 3 and 9 months ] [ Designated as safety issue: No ]
Social functioning [ Time Frame: Baseline, 3 abd 9 months ] [ Designated as safety issue: No ]
Hope [ Time Frame: Baseline, 3 and 9 months ] [ Designated as safety issue: No ]
Self-determination [ Time Frame: Baseline, 3 and 9 months ] [ Designated as safety issue: No ]
Functional status [ Time Frame: Baseline, 3 and 9 months ] [ Designated as safety issue: No ]
Treatment relationship [ Time Frame: Baseline, 3 and 9 months ] [ Designated as safety issue: No ]

Estimated Enrollment:	120
Study Start Date:	December 2006
Estimated Study Completion Date:	April 2009
Estimated Primary Completion Date:	April 2009 (Final data collection date for primary outcome measure)

Arms	Assigned Interventions
1: Experimental Recovery Mentor	Behavioral: Recovery Mentor Provided Recovery Mentor services
0: No Intervention No Recovery Mentor, services as usual

Detailed Description:

The paradigm shift in mental health treatment from a deficit-and institution- based framework to a recovery and community integration frame necessitates new models of "case management" practices. The Recovery Guide model is just such a model. Beyond theoretical frameworks, the effectiveness of Recovery Guides has not been well studied. It is the intent of this study to conduct a randomized trial examining the effects of Recovery Guides on community tenure and integration. Furthermore, it is the intent of this study to to establish fidelity criteria.

Comparison(s): Recovery Guide services in addition to treatment as usual, compared to treatment as usual.

Eligibility

Ages Eligible for Study:	18 Years to 80 Years
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No

Criteria

Inclusion Criteria:

18 years of age or older
Currently admitted in the Yale-New Haven Psychiatric Hospital (YNHPH)
A history of two or more prior admissions within the past 18 months
Proficient in the use of the English language
A DSM-IV diagnosis of Schizophrenia, Schizoaffective Disorder, Psychotic Disorder NOS, or Major Depressive Disorder with Psychotic Features

Exclusion Criteria:

Inability to give signed, written consent
Primary DSM-IV diagnosis of substance abuse/dependence

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00400166

Contacts

Contact: Dave Sells, PhD	203-764-8691	david.sells@yale.edu
Contact: Larry Davidson, PhD	203-764-7583	larry.davidson@yale.edu

Locations

United States, Connecticut
Yale-New Haven Psychiatric Hospital	Recruiting
New Haven, Connecticut, United States, 06519
Principal Investigator: William H Sledge, MD

Sponsors and Collaborators

Yale University

Connecticut State, Department of Mental Health and Addiction Services

Eli Lilly and Company

Investigators

Principal Investigator:

William H Sledge, MD

Yale University

More Information

Additional Information:

Yale Program for Recovery and Community Health This link exits the ClinicalTrials.gov site

No publications provided

Responsible Party:	Yale University School of Medicine ( William H. Sledge, M.D.; Director, Yale Psychiatric Hospital; Chair, Yale Department of Psychiatry; George D & Esther S Gross Professor of Psychiatry )
Study ID Numbers:	0607001641
Study First Received:	November 15, 2006
Last Updated:	March 2, 2009
ClinicalTrials.gov Identifier:	NCT00400166 History of Changes
Health Authority:	United States: Institutional Review Board

Keywords provided by Yale University:

Peer support
Psychiatric disability
Mutual support
Psychiatric Rehabilitation

Study placed in the following topic categories:

Schizophrenia
Affective Disorders, Psychotic
Depression
Mental Disorders
Bipolar Disorder
Mood Disorders

Psychotic Disorders
Depressive Disorder, Major
Depressive Disorder
Schizophrenia and Disorders with Psychotic Features
Recurrence
Behavioral Symptoms

Additional relevant MeSH terms:

Depression
Disease
Bipolar Disorder
Depressive Disorder, Major
Depressive Disorder
Behavioral Symptoms
Schizophrenia

Affective Disorders, Psychotic
Pathologic Processes
Mental Disorders
Mood Disorders
Psychotic Disorders
Schizophrenia and Disorders with Psychotic Features

ClinicalTrials.gov processed this record on May 06, 2009